Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)
June 14 2013 - 9:38AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification
and Notice of Termination of Registration Under Section 12(
g
)
of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(
d
)
of the Securities Exchange Act of 1934
Commission File Number 333-152286
GLOBAL PHARM HOLDINGS GROUP, INC.
|
(Exact name of registrant as specified in its charter)
|
25/F, New World Center, No. 6009 Yitian
Road,
Futian District, Shenzhen City, China,
518026
+86-755-8303 9661
|
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
|
Common Stock, par value $0.01 per share
|
(Title of each class of securities covered by this Form)
|
None
|
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
|
Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
|
x
|
Rule 12g-4(a)(2)
|
¨
|
Rule 12h-3(b)(1)(i)
|
x
|
Rule 12h-3(b)(1)(ii)
|
¨
|
Rule 15d-6
|
¨
|
Approximate number of holders of record
as of the certification or notice date: 22.
Pursuant
to the requirements of the Securities Exchange Act of 1934,
Global Pharm Holdings Group, Inc.
has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date:
|
|
June 14, 2013
|
|
By:
|
|
/s/ Yunlu Yin
|
|
|
|
|
|
|
Name: Yunlu Yin
|
|
|
|
|
|
|
Title: Chief Executive Officer
|
Global Pharm (CE) (USOTC:GPHG)
Historical Stock Chart
From Apr 2024 to May 2024
Global Pharm (CE) (USOTC:GPHG)
Historical Stock Chart
From May 2023 to May 2024